Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries.

Rayner A, Fotheringham J, Thokala P, Soro M, Carrero JJ, Faucon AL

Open source

DOI
10.1007/s12325-026-03735-9
Published
2026 Aug 10
Container
Advances in therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03735-9,
  title = {Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries.},
  author = {Rayner A and Fotheringham J and Thokala P and Soro M and Carrero JJ and Faucon AL},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-026-03735-9},
  url = {https://doi.org/10.1007/s12325-026-03735-9}
}

RIS

TY  - JOUR
TI  - Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries.
AU  - Rayner A
AU  - Fotheringham J
AU  - Thokala P
AU  - Soro M
AU  - Carrero JJ
AU  - Faucon AL
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-026-03735-9
UR  - https://doi.org/10.1007/s12325-026-03735-9
ER  - 

APA

A, R., J, F., P, T., M, S., JJ, C., & AL, F. (2026). Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries.. Advances in therapy. https://doi.org/10.1007/s12325-026-03735-9

Source records